Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Investors dive into bonds as global AI tech selloff continues

November 6, 2026

‘Kate & Allie’ star Susan Saint James cause of death revealed

November 6, 2026

Crossing guard hit in Richmond Hill crash following string of pedestrian collisions

November 6, 2026

This see-through camera lets photographers maintain eye contact with their subjects

November 6, 2026

U of T’s dentistry dean to step down following antisemitic images in course material

November 6, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » MLTX 4-DAY DEADLINE ALERT: MoonLake (MLTX) Class Action Lawsuit – Hagens Berman Scrutinizing Nanobody Superiority Claims After 90% Plunge; December Lead Plaintiff Deadline Looms
Press Release

MLTX 4-DAY DEADLINE ALERT: MoonLake (MLTX) Class Action Lawsuit – Hagens Berman Scrutinizing Nanobody Superiority Claims After 90% Plunge; December Lead Plaintiff Deadline Looms

By News RoomDecember 11, 20253 Mins Read
MLTX 4-DAY DEADLINE ALERT: MoonLake (MLTX) Class Action Lawsuit – Hagens Berman Scrutinizing Nanobody Superiority Claims After 90% Plunge; December Lead Plaintiff Deadline Looms
Share
Facebook Twitter LinkedIn Pinterest Email

SAN FRANCISCO, Dec. 11, 2025 (GLOBE NEWSWIRE) — Global plaintiffs’ rights firm Hagens Berman reminds investors that the Lead Plaintiff Deadline in the securities class action lawsuit against MoonLake Immunotherapeutics (NASDAQ: MLTX) is rapidly approaching: December 15, 2025.

The lawsuit alleges that MoonLake and certain executives made materially false and misleading statements regarding the clinical prospects of the company’s lead and sole drug candidate, sonelokimab (SLK), causing the stock to crash nearly 90% on the revelation of disappointing Phase 3 trial results. Hagens Berman urges investors with significant losses to submit their losses now.

The Lawsuit’s Core Allegation: The Nanobody Deception

The lawsuit focuses on the company’s repeated claims that SLK’s distinctive Nanobody structure would translate into superior clinical efficacy (like higher HiSCR75 responses) compared to conventional monoclonal antibody treatments, specifically the FDA-approved competitor BIMZELX.

“We are focusing on the repeated assurances MoonLake gave investors about the supposed ‘superiority’ of their Nanobody technology. When the VELA-2 results came out, those promises evaporated, and investors lost nearly everything overnight,” said Reed Kathrein, the Hagens Berman partner leading the litigation. “As the December 15 deadline approaches, we encourage investors who suffered heavy losses to contact the firm to discuss their rights.”

Timeline and Key Details:

Issuer   MoonLake Immunotherapeutics (MLTX)
Class Period   March 10, 2024 – September 29, 2025
Lead Plaintiff Deadline   December 15, 2025
Stock Drop Event   Stock fell from $61.99 to $6.24 (a 90% loss) on September 29, 2025, after VELA-2 trial failed its primary endpoint and efficacy was shown to be inferior to a competitor.
     
     



Next Steps for MoonLake (MLTX) Investors:

Investors who purchased MoonLake stock (MLTX) between March 10, 2024, and September 29, 2025, and suffered substantial losses, are encouraged to contact Hagens Berman immediately to discuss their legal options and potential appointment as Lead Plaintiff.

TO SUBMIT YOUR MOONLAKE (MLTX) STOCK LOSSES AND DISCUSS THE NANOBODY EFFICACY ALLEGATIONS, PLEASE USE THE SECURE FORM BELOW:

Contact Partner Reed Kathrein:

Whistleblowers: Persons with non-public information regarding MoonLake should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected].

About Hagens Berman
Hagens Berman is a global plaintiffs’ rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman’s team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw.

Contact:
Reed Kathrein, 844-916-0895

A photo accompanying this announcement is available at: https://www.globenewswire.com/NewsRoom/AttachmentNg/b8ff33dd-6b12-4384-92c6-94d3cacaa080

A video accompanying this announcement is available at: https://www.globenewswire.com/NewsRoom/AttachmentNg/9c9a8b56-a65f-4bab-9e1d-7c7fc6c23c03

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

vineyard vines Returns as Official Style of the Head Of The Charles® Regatta

Bigger & Better Than Ever: Laxmi & Chef Kunal Kapur Return With ‘Diwali Delights’ Season 2

2026 Chery International User Summit to Kick Off: LUXEED Set for Global Brand Launch

Going Asset Management Wins Capital’s Excellence Fund Award, Harnessing Technology to Enhance the Long-Term Value of Assets

Alation Honors 2026 AI Radicals Award Winners at revAlation

Supported Employment: Helping Individuals Build Meaningful Careers

“The Carbon Pursuit of Happiness” Premieres October 10: A New Chapter for In-Depth Dialogue on Health and Humanity

Evolution Metals & Technologies Corp. Raises Fiscal 2026 Revenue Guidance 62% at Midpoint to 11 Million and Reaffirms 460 Million Fiscal 2027 Outlook

Ufunded Launches “Spotlight” Series, Documenting the Minds Shaping Modern Trading

Editors Picks

‘Kate & Allie’ star Susan Saint James cause of death revealed

November 6, 2026

Crossing guard hit in Richmond Hill crash following string of pedestrian collisions

November 6, 2026

This see-through camera lets photographers maintain eye contact with their subjects

November 6, 2026

U of T’s dentistry dean to step down following antisemitic images in course material

November 6, 2026

Latest News

TikTok’s For You page needs to change, says the EU

November 6, 2026

Cineplex posts record revenue as Spider-Man, Odyssey drove moviegoers

November 6, 2026

Budget 2026 proposes 1st deposit insurance limit increase in 2 decades

November 6, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version